img

Global Nonalcoholic Steatohepatitis Treatment Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Nonalcoholic Steatohepatitis Treatment Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Nonalcoholic steatohepatitis is a syndrome causes liver damage develops in the individuals who are not alcoholic. The primary mechanisms of nonalcoholic steatohepatitis are obesity, glucose intolerance, metabolic stress, inflammation, dyslipidemia and fibrosis. Nonalcoholic steatohepatitis can develop into cirrhosis and liver cancer. For the diagnosis of the nonalcoholic steatohepatitis, liver biopsy, imaging procedures and various types of blood tests including complete blood count, fasting blood sugar, liver enzyme tests etc. are required. The common nonalcoholic steatohepatitis treatment may include weight loss, type-2 diabetes treatment, a decrease of obesity etc. However, many drugs have been tested for the nonalcoholic steatohepatitis treatment only a few drugs such as vitamin E and pioglitazone showed a positive effect. Other drugs such as ursodeoxycholic acid, metformin, statins, orlistat and pentoxifylline showed only partially positive results.The major elements that can be considered for the pathological protagonists of nonalcoholic steatohepatitis are oxidative stress, altered lipid metabolism adipose and pancreas tissues, bile acids, gut microbiota, bacterial endotoxins, and systemic chronic inflammation.
Nonalcoholic Steatohepatitis Treatment report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Nonalcoholic Steatohepatitis Treatment market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Diagnostic Center are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Nonalcoholic Steatohepatitis Treatment industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Nonalcoholic Steatohepatitis Treatment key manufacturers include AstraZeneca, Arena Pharmaceuticals, GSK, Novo Nordisk, Roche, Vivus, Arisaph Pharmaceuticals, Cempra Pharmaceuticals and Galectin Therapeutics, etc. AstraZeneca, Arena Pharmaceuticals, GSK are top 3 players and held % sales share in total in 2022.
Nonalcoholic Steatohepatitis Treatment can be divided into Solid and Liquid, etc. Solid is the mainstream product in the market, accounting for % sales share globally in 2022.
Nonalcoholic Steatohepatitis Treatment is widely used in various fields, such as Hospital, Diagnostic Center, Specialized Clinic and Hospital Pharmacy, etc. Hospital provides greatest supports to the Nonalcoholic Steatohepatitis Treatment industry development. In 2022, global % sales of Nonalcoholic Steatohepatitis Treatment went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Nonalcoholic Steatohepatitis Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


AstraZeneca
Arena Pharmaceuticals
GSK
Novo Nordisk
Roche
Vivus
Arisaph Pharmaceuticals
Cempra Pharmaceuticals
Galectin Therapeutics
Galmed Pharmaceuticals
Genfit
Gilead
Segment by Type
Solid
Liquid

Segment by Application


Hospital
Diagnostic Center
Specialized Clinic
Hospital Pharmacy
Drug Store
Mail Order Pharmacy

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Nonalcoholic Steatohepatitis Treatment market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Nonalcoholic Steatohepatitis Treatment, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Nonalcoholic Steatohepatitis Treatment industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Nonalcoholic Steatohepatitis Treatment in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Nonalcoholic Steatohepatitis Treatment introduction, etc. Nonalcoholic Steatohepatitis Treatment Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Nonalcoholic Steatohepatitis Treatment market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Nonalcoholic Steatohepatitis Treatment Market Overview
1.1 Nonalcoholic Steatohepatitis Treatment Product Overview
1.2 Nonalcoholic Steatohepatitis Treatment Market Segment by Type
1.2.1 Solid
1.2.2 Liquid
1.3 Global Nonalcoholic Steatohepatitis Treatment Market Size by Type
1.3.1 Global Nonalcoholic Steatohepatitis Treatment Market Size Overview by Type (2024-2034)
1.3.2 Global Nonalcoholic Steatohepatitis Treatment Historic Market Size Review by Type (2024-2024)
1.3.3 Global Nonalcoholic Steatohepatitis Treatment Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Type (2024-2024)
1.4.2 Europe Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Type (2024-2024)
2 Global Nonalcoholic Steatohepatitis Treatment Market Competition by Company
2.1 Global Top Players by Nonalcoholic Steatohepatitis Treatment Sales (2024-2024)
2.2 Global Top Players by Nonalcoholic Steatohepatitis Treatment Revenue (2024-2024)
2.3 Global Top Players by Nonalcoholic Steatohepatitis Treatment Price (2024-2024)
2.4 Global Top Manufacturers Nonalcoholic Steatohepatitis Treatment Manufacturing Base Distribution, Sales Area, Product Type
2.5 Nonalcoholic Steatohepatitis Treatment Market Competitive Situation and Trends
2.5.1 Nonalcoholic Steatohepatitis Treatment Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Nonalcoholic Steatohepatitis Treatment Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nonalcoholic Steatohepatitis Treatment as of 2022)
2.7 Date of Key Manufacturers Enter into Nonalcoholic Steatohepatitis Treatment Market
2.8 Key Manufacturers Nonalcoholic Steatohepatitis Treatment Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Nonalcoholic Steatohepatitis Treatment Status and Outlook by Region
3.1 Global Nonalcoholic Steatohepatitis Treatment Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Nonalcoholic Steatohepatitis Treatment Historic Market Size by Region
3.2.1 Global Nonalcoholic Steatohepatitis Treatment Sales in Volume by Region (2024-2024)
3.2.2 Global Nonalcoholic Steatohepatitis Treatment Sales in Value by Region (2024-2024)
3.2.3 Global Nonalcoholic Steatohepatitis Treatment Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Nonalcoholic Steatohepatitis Treatment Forecasted Market Size by Region
3.3.1 Global Nonalcoholic Steatohepatitis Treatment Sales in Volume by Region (2024-2034)
3.3.2 Global Nonalcoholic Steatohepatitis Treatment Sales in Value by Region (2024-2034)
3.3.3 Global Nonalcoholic Steatohepatitis Treatment Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Nonalcoholic Steatohepatitis Treatment by Application
4.1 Nonalcoholic Steatohepatitis Treatment Market Segment by Application
4.1.1 Hospital
4.1.2 Diagnostic Center
4.1.3 Specialized Clinic
4.1.4 Hospital Pharmacy
4.1.5 Drug Store
4.1.6 Mail Order Pharmacy
4.2 Global Nonalcoholic Steatohepatitis Treatment Market Size by Application
4.2.1 Global Nonalcoholic Steatohepatitis Treatment Market Size Overview by Application (2024-2034)
4.2.2 Global Nonalcoholic Steatohepatitis Treatment Historic Market Size Review by Application (2024-2024)
4.2.3 Global Nonalcoholic Steatohepatitis Treatment Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Application (2024-2024)
4.3.2 Europe Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales Breakdown by Application (2024-2024)
5 North America Nonalcoholic Steatohepatitis Treatment by Country
5.1 North America Nonalcoholic Steatohepatitis Treatment Historic Market Size by Country
5.1.1 North America Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Nonalcoholic Steatohepatitis Treatment Sales in Volume by Country (2024-2024)
5.1.3 North America Nonalcoholic Steatohepatitis Treatment Sales in Value by Country (2024-2024)
5.2 North America Nonalcoholic Steatohepatitis Treatment Forecasted Market Size by Country
5.2.1 North America Nonalcoholic Steatohepatitis Treatment Sales in Volume by Country (2024-2034)
5.2.2 North America Nonalcoholic Steatohepatitis Treatment Sales in Value by Country (2024-2034)
6 Europe Nonalcoholic Steatohepatitis Treatment by Country
6.1 Europe Nonalcoholic Steatohepatitis Treatment Historic Market Size by Country
6.1.1 Europe Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Nonalcoholic Steatohepatitis Treatment Sales in Volume by Country (2024-2024)
6.1.3 Europe Nonalcoholic Steatohepatitis Treatment Sales in Value by Country (2024-2024)
6.2 Europe Nonalcoholic Steatohepatitis Treatment Forecasted Market Size by Country
6.2.1 Europe Nonalcoholic Steatohepatitis Treatment Sales in Volume by Country (2024-2034)
6.2.2 Europe Nonalcoholic Steatohepatitis Treatment Sales in Value by Country (2024-2034)
7 Asia-Pacific Nonalcoholic Steatohepatitis Treatment by Region
7.1 Asia-Pacific Nonalcoholic Steatohepatitis Treatment Historic Market Size by Region
7.1.1 Asia-Pacific Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Nonalcoholic Steatohepatitis Treatment Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Nonalcoholic Steatohepatitis Treatment Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Nonalcoholic Steatohepatitis Treatment Forecasted Market Size by Region
7.2.1 Asia-Pacific Nonalcoholic Steatohepatitis Treatment Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Nonalcoholic Steatohepatitis Treatment Sales in Value by Region (2024-2034)
8 Latin America Nonalcoholic Steatohepatitis Treatment by Country
8.1 Latin America Nonalcoholic Steatohepatitis Treatment Historic Market Size by Country
8.1.1 Latin America Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Nonalcoholic Steatohepatitis Treatment Sales in Volume by Country (2024-2024)
8.1.3 Latin America Nonalcoholic Steatohepatitis Treatment Sales in Value by Country (2024-2024)
8.2 Latin America Nonalcoholic Steatohepatitis Treatment Forecasted Market Size by Country
8.2.1 Latin America Nonalcoholic Steatohepatitis Treatment Sales in Volume by Country (2024-2034)
8.2.2 Latin America Nonalcoholic Steatohepatitis Treatment Sales in Value by Country (2024-2034)
9 Middle East and Africa Nonalcoholic Steatohepatitis Treatment by Country
9.1 Middle East and Africa Nonalcoholic Steatohepatitis Treatment Historic Market Size by Country
9.1.1 Middle East and Africa Nonalcoholic Steatohepatitis Treatment Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Nonalcoholic Steatohepatitis Treatment Forecasted Market Size by Country
9.2.1 Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 AstraZeneca
10.1.1 AstraZeneca Company Information
10.1.2 AstraZeneca Introduction and Business Overview
10.1.3 AstraZeneca Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2024-2024)
10.1.4 AstraZeneca Nonalcoholic Steatohepatitis Treatment Products Offered
10.1.5 AstraZeneca Recent Development
10.2 Arena Pharmaceuticals
10.2.1 Arena Pharmaceuticals Company Information
10.2.2 Arena Pharmaceuticals Introduction and Business Overview
10.2.3 Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Products Offered
10.2.5 Arena Pharmaceuticals Recent Development
10.3 GSK
10.3.1 GSK Company Information
10.3.2 GSK Introduction and Business Overview
10.3.3 GSK Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2024-2024)
10.3.4 GSK Nonalcoholic Steatohepatitis Treatment Products Offered
10.3.5 GSK Recent Development
10.4 Novo Nordisk
10.4.1 Novo Nordisk Company Information
10.4.2 Novo Nordisk Introduction and Business Overview
10.4.3 Novo Nordisk Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Novo Nordisk Nonalcoholic Steatohepatitis Treatment Products Offered
10.4.5 Novo Nordisk Recent Development
10.5 Roche
10.5.1 Roche Company Information
10.5.2 Roche Introduction and Business Overview
10.5.3 Roche Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Roche Nonalcoholic Steatohepatitis Treatment Products Offered
10.5.5 Roche Recent Development
10.6 Vivus
10.6.1 Vivus Company Information
10.6.2 Vivus Introduction and Business Overview
10.6.3 Vivus Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Vivus Nonalcoholic Steatohepatitis Treatment Products Offered
10.6.5 Vivus Recent Development
10.7 Arisaph Pharmaceuticals
10.7.1 Arisaph Pharmaceuticals Company Information
10.7.2 Arisaph Pharmaceuticals Introduction and Business Overview
10.7.3 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Products Offered
10.7.5 Arisaph Pharmaceuticals Recent Development
10.8 Cempra Pharmaceuticals
10.8.1 Cempra Pharmaceuticals Company Information
10.8.2 Cempra Pharmaceuticals Introduction and Business Overview
10.8.3 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Products Offered
10.8.5 Cempra Pharmaceuticals Recent Development
10.9 Galectin Therapeutics
10.9.1 Galectin Therapeutics Company Information
10.9.2 Galectin Therapeutics Introduction and Business Overview
10.9.3 Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Products Offered
10.9.5 Galectin Therapeutics Recent Development
10.10 Galmed Pharmaceuticals
10.10.1 Galmed Pharmaceuticals Company Information
10.10.2 Galmed Pharmaceuticals Introduction and Business Overview
10.10.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Products Offered
10.10.5 Galmed Pharmaceuticals Recent Development
10.11 Genfit
10.11.1 Genfit Company Information
10.11.2 Genfit Introduction and Business Overview
10.11.3 Genfit Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Genfit Nonalcoholic Steatohepatitis Treatment Products Offered
10.11.5 Genfit Recent Development
10.12 Gilead
10.12.1 Gilead Company Information
10.12.2 Gilead Introduction and Business Overview
10.12.3 Gilead Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Gilead Nonalcoholic Steatohepatitis Treatment Products Offered
10.12.5 Gilead Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Nonalcoholic Steatohepatitis Treatment Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Nonalcoholic Steatohepatitis Treatment Industrial Chain Analysis
11.4 Nonalcoholic Steatohepatitis Treatment Market Dynamics
11.4.1 Nonalcoholic Steatohepatitis Treatment Industry Trends
11.4.2 Nonalcoholic Steatohepatitis Treatment Market Drivers
11.4.3 Nonalcoholic Steatohepatitis Treatment Market Challenges
11.4.4 Nonalcoholic Steatohepatitis Treatment Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Nonalcoholic Steatohepatitis Treatment Distributors
12.3 Nonalcoholic Steatohepatitis Treatment Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Solid
Table 2. Major Company of Liquid
Table 3. Global Nonalcoholic Steatohepatitis Treatment Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Nonalcoholic Steatohepatitis Treatment Sales by Type (2024-2024) & (K Units)
Table 5. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Nonalcoholic Steatohepatitis Treatment Sales by Type (2024-2024) & (US& Million)
Table 7. Global Nonalcoholic Steatohepatitis Treatment Market Share in Value by Type (2024-2024)
Table 8. Global Nonalcoholic Steatohepatitis Treatment Price by Type (2024-2024) & (US$/Unit)
Table 9. Global Nonalcoholic Steatohepatitis Treatment Sales by Type (2024-2034) & (K Units)
Table 10. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Nonalcoholic Steatohepatitis Treatment Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share in Value by Type (2024-2034)
Table 13. Global Nonalcoholic Steatohepatitis Treatment Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Nonalcoholic Steatohepatitis Treatment Sales by Type (2024-2024) & (K Units)
Table 15. North America Nonalcoholic Steatohepatitis Treatment Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Nonalcoholic Steatohepatitis Treatment Sales (K Units) by Type (2024-2024)
Table 17. Europe Nonalcoholic Steatohepatitis Treatment Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Nonalcoholic Steatohepatitis Treatment Sales (K Units) by Type (2024-2024)
Table 21. Latin America Nonalcoholic Steatohepatitis Treatment Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Nonalcoholic Steatohepatitis Treatment Sales by Company (2024-2024) & (K Units)
Table 25. Global Nonalcoholic Steatohepatitis Treatment Sales Share by Company (2024-2024)
Table 26. Global Nonalcoholic Steatohepatitis Treatment Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Nonalcoholic Steatohepatitis Treatment Revenue Share by Company (2024-2024)
Table 28. Global Market Nonalcoholic Steatohepatitis Treatment Price by Company (2024-2024) & (US$/Unit)
Table 29. Global Nonalcoholic Steatohepatitis Treatment Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Nonalcoholic Steatohepatitis Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nonalcoholic Steatohepatitis Treatment as of 2022)
Table 32. Date of Key Manufacturers Enter into Nonalcoholic Steatohepatitis Treatment Market
Table 33. Key Manufacturers Nonalcoholic Steatohepatitis Treatment Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Nonalcoholic Steatohepatitis Treatment Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Nonalcoholic Steatohepatitis Treatment Sales by Region (2024-2024) & (K Units)
Table 37. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Nonalcoholic Steatohepatitis Treatment Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share in Value by Region (2024-2024)
Table 40. Global Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global Nonalcoholic Steatohepatitis Treatment Sales by Region (2024-2034) & (K Units)
Table 42. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Nonalcoholic Steatohepatitis Treatment Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share in Value by Region (2024-2034)
Table 45. Global Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Nonalcoholic Steatohepatitis Treatment Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Nonalcoholic Steatohepatitis Treatment Sales by Application (2024-2024) & (K Units)
Table 48. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Nonalcoholic Steatohepatitis Treatment Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share in Value by Application (2024-2024)
Table 51. Global Nonalcoholic Steatohepatitis Treatment Price by Application (2024-2024) & (US$/Unit)
Table 52. Global Nonalcoholic Steatohepatitis Treatment Sales by Application (2024-2034) & (K Units)
Table 53. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Nonalcoholic Steatohepatitis Treatment Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share in Value by Application (2024-2034)
Table 56. Global Nonalcoholic Steatohepatitis Treatment Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Nonalcoholic Steatohepatitis Treatment Sales by Application (2024-2024) (K Units)
Table 58. North America Nonalcoholic Steatohepatitis Treatment Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Nonalcoholic Steatohepatitis Treatment Sales by Application (2024-2024) (K Units)
Table 60. Europe Nonalcoholic Steatohepatitis Treatment Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Nonalcoholic Steatohepatitis Treatment Sales by Application (2024-2024) (K Units)
Table 64. Latin America Nonalcoholic Steatohepatitis Treatment Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Nonalcoholic Steatohepatitis Treatment Sales by Country (2024-2024) & (K Units)
Table 68. North America Nonalcoholic Steatohepatitis Treatment Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Nonalcoholic Steatohepatitis Treatment Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Nonalcoholic Steatohepatitis Treatment Sales Market Share in Value by Country (2024-2024)
Table 71. North America Nonalcoholic Steatohepatitis Treatment Sales by Country (2024-2034) & (K Units)
Table 72. North America Nonalcoholic Steatohepatitis Treatment Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Nonalcoholic Steatohepatitis Treatment Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Nonalcoholic Steatohepatitis Treatment Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Nonalcoholic Steatohepatitis Treatment Sales by Country (2024-2024) & (K Units)
Table 76. Europe Nonalcoholic Steatohepatitis Treatment Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Nonalcoholic Steatohepatitis Treatment Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Nonalcoholic Steatohepatitis Treatment Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Nonalcoholic Steatohepatitis Treatment Sales by Country (2024-2034) & (K Units)
Table 80. Europe Nonalcoholic Steatohepatitis Treatment Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Nonalcoholic Steatohepatitis Treatment Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Nonalcoholic Steatohepatitis Treatment Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Nonalcoholic Steatohepatitis Treatment Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Nonalcoholic Steatohepatitis Treatment Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Nonalcoholic Steatohepatitis Treatment Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Nonalcoholic Steatohepatitis Treatment Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Nonalcoholic Steatohepatitis Treatment Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Nonalcoholic Steatohepatitis Treatment Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Nonalcoholic Steatohepatitis Treatment Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Nonalcoholic Steatohepatitis Treatment Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales Market Share in Value by Country (2024-2034)
Table 107. AstraZeneca Company Information
Table 108. AstraZeneca Introduction and Business Overview
Table 109. AstraZeneca Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. AstraZeneca Nonalcoholic Steatohepatitis Treatment Product
Table 111. AstraZeneca Recent Development
Table 112. Arena Pharmaceuticals Company Information
Table 113. Arena Pharmaceuticals Introduction and Business Overview
Table 114. Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product
Table 116. Arena Pharmaceuticals Recent Development
Table 117. GSK Company Information
Table 118. GSK Introduction and Business Overview
Table 119. GSK Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. GSK Nonalcoholic Steatohepatitis Treatment Product
Table 121. GSK Recent Development
Table 122. Novo Nordisk Company Information
Table 123. Novo Nordisk Introduction and Business Overview
Table 124. Novo Nordisk Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. Novo Nordisk Nonalcoholic Steatohepatitis Treatment Product
Table 126. Novo Nordisk Recent Development
Table 127. Roche Company Information
Table 128. Roche Introduction and Business Overview
Table 129. Roche Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Roche Nonalcoholic Steatohepatitis Treatment Product
Table 131. Roche Recent Development
Table 132. Vivus Company Information
Table 133. Vivus Introduction and Business Overview
Table 134. Vivus Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. Vivus Nonalcoholic Steatohepatitis Treatment Product
Table 136. Vivus Recent Development
Table 137. Arisaph Pharmaceuticals Company Information
Table 138. Arisaph Pharmaceuticals Introduction and Business Overview
Table 139. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product
Table 141. Arisaph Pharmaceuticals Recent Development
Table 142. Cempra Pharmaceuticals Company Information
Table 143. Cempra Pharmaceuticals Introduction and Business Overview
Table 144. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product
Table 146. Cempra Pharmaceuticals Recent Development
Table 147. Galectin Therapeutics Company Information
Table 148. Galectin Therapeutics Introduction and Business Overview
Table 149. Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Product
Table 151. Galectin Therapeutics Recent Development
Table 152. Galmed Pharmaceuticals Company Information
Table 153. Galmed Pharmaceuticals Introduction and Business Overview
Table 154. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 155. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product
Table 156. Galmed Pharmaceuticals Recent Development
Table 157. Genfit Company Information
Table 158. Genfit Introduction and Business Overview
Table 159. Genfit Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 160. Genfit Nonalcoholic Steatohepatitis Treatment Product
Table 161. Genfit Recent Development
Table 162. Gilead Company Information
Table 163. Gilead Introduction and Business Overview
Table 164. Gilead Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 165. Gilead Nonalcoholic Steatohepatitis Treatment Product
Table 166. Gilead Recent Development
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Nonalcoholic Steatohepatitis Treatment Market Trends
Table 170. Nonalcoholic Steatohepatitis Treatment Market Drivers
Table 171. Nonalcoholic Steatohepatitis Treatment Market Challenges
Table 172. Nonalcoholic Steatohepatitis Treatment Market Restraints
Table 173. Nonalcoholic Steatohepatitis Treatment Distributors List
Table 174. Nonalcoholic Steatohepatitis Treatment Downstream Customers
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Nonalcoholic Steatohepatitis Treatment Product Picture
Figure 2. Global Nonalcoholic Steatohepatitis Treatment Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Nonalcoholic Steatohepatitis Treatment Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Nonalcoholic Steatohepatitis Treatment Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Solid
Figure 6. Global Solid Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Liquid
Figure 8. Global Liquid Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Nonalcoholic Steatohepatitis Treatment Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type in 2022 & 2034
Figure 11. North America Nonalcoholic Steatohepatitis Treatment Sales Market Share in Volume by Type in 2022
Figure 12. North America Nonalcoholic Steatohepatitis Treatment Sales Market Share in Value by Type in 2022
Figure 13. Europe Nonalcoholic Steatohepatitis Treatment Sales Market Share in Volume by Type in 2022
Figure 14. Europe Nonalcoholic Steatohepatitis Treatment Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Sales Market Share in Value by Type in 2022
Figure 17. Latin America Nonalcoholic Steatohepatitis Treatment Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Nonalcoholic Steatohepatitis Treatment Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Nonalcoholic Steatohepatitis Treatment Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Nonalcoholic Steatohepatitis Treatment Revenue in 2022
Figure 23. Nonalcoholic Steatohepatitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Diagnostic Center
Figure 27. Global Diagnostic Center Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Specialized Clinic
Figure 29. Global Specialized Clinic Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Hospital Pharmacy
Figure 31. Global Hospital Pharmacy Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Drug Store
Figure 33. Global Drug Store Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Product Picture of Mail Order Pharmacy
Figure 35. Global Mail Order Pharmacy Sales YoY Growth (2024-2034) & (K Units)
Figure 36. Global Nonalcoholic Steatohepatitis Treatment Sales by Application (2024-2034) & (US$ Million)
Figure 37. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application in 2022 & 2034
Figure 38. North America Nonalcoholic Steatohepatitis Treatment Sales Market Share in Volume by Application in 2022
Figure 39. North America Nonalcoholic Steatohepatitis Treatment Sales Market Share in Value by Application in 2022
Figure 40. Europe Nonalcoholic Steatohepatitis Treatment Sales Market Share in Volume by Application in 2022
Figure 41. Europe Nonalcoholic Steatohepatitis Treatment Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Nonalcoholic Steatohepatitis Treatment Sales Market Share in Value by Application in 2022
Figure 44. Latin America Nonalcoholic Steatohepatitis Treatment Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Nonalcoholic Steatohepatitis Treatment Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Nonalcoholic Steatohepatitis Treatment Manufacturing Cost Structure
Figure 49. Nonalcoholic Steatohepatitis Treatment Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries